Holding(s) in Company

Summary by AI BETAClose X

Spreadex LTD has notified CRISM Therapeutics Corporation of a change in its major holdings, crossing a threshold on June 18, 2026. Following this event, Spreadex LTD now holds a total of 3.473300% of the voting rights, comprising 2.525700% directly attached to shares and 0.947600% through financial instruments, specifically CFDs/Spread Bets, representing a total of 2,750,374 voting rights. This represents a decrease from their previous notification where they held 2.941200% of voting rights.

Disclaimer*

UK 100

Latest directors dealings